The role of matrin 3 in the pathogenesis of amyotrophic lateral sclerosis by Wang, Hao
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2015
The role of matrin 3 in the
pathogenesis of amyotrophic
lateral sclerosis
https://hdl.handle.net/2144/16177
Boston University
	   	   	  
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
 
THE ROLE OF MATRIN 3 IN THE PATHOGENESIS OF 
AMYOTROPHIC LATERAL SCLEROSIS 
 
 
 
 
by 
 
 
 
HAO WANG 
 
B.S., University of Massachusetts–Amherst, 2012 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2015  
	   	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                  © 2015 by 
 HAO WANG 
 All rights reserved  
	   	   	  
Approved by 
 
 
 
 
First Reader   
 Benjamin Wolozin M.D., Ph.D. 
 Professor of Pharmacology and Neurology 
 
 
Second Reader   
 Fernando Garcia-Diaz Ph.D. 
 Associate Professor of Physiology and Biophysics 
 
 
	  	   iv	  
ACKNOWLEDGMENTS 
 
I would like to thank my PI, Dr. Benjamin Wolozin for all the advices and support that he 
has given me. Special thanks to Shamol, Pete, Dan and Tara for giving me valuable 
advice on my experimental techniques. Last but not least, I sincerely thank my long-time 
friend Dan Shatil for helping me with my revisions.   
	  	   v	  
THE ROLE OF MATRIN 3 IN THE PATHOGENESIS OF 
AMYOTROPHIC LATERAL SCLEROSIS 
HAO WANG 
ABSTRACT 
The cause of amyotrophic lateral sclerosis (ALS), a cruel neurodegenerative disease, 
remains unclear. Trans-activating response region (TAR) DNA-binding protein of 43 
kDa (TDP-43) has been suggested to have an important role in ALS pathogenesis. In this 
thesis, we show that a disease linked mutation in matrin 3 (MATR3), a DNA/RNA-
binding protein, corresponds to an increased tendency for TDP-43 to aggregate into large 
and more numerous cytoplasmic inclusions that are the hallmark of ALS. 
Immunocytochemistry experiments show that MATR3 colocalizes with TDP-43 in vitro. 
These experiments also show TDP-43 is a component of both MATR3 granules and 
stress granules, and that MATR3 inclusions are directly adjacent to stress granules or 
eIF3α inclusions. We hypothesize that, while not being a part of stress granule complex, 
MATR3 granules are involved in RNA processing via the stress granule pathway by 
relaying crucial components such as TDP-43. We have also found that compound 8J is 
able to disaggregate and relocate TDP-43 and MATR3 positive inclusions in vitro. While 
the mechanism of action of compound 8J remains unclear, fluorescence activated cell 
sorting (FACS) experiment showed that there was a significant increase in viability in 
double wild type (matrin 3 and TDP-43) cells when treated with C8J (p-value <.001), 
which suggests that the TDP-43 and MATR3 cytoplasmic inclusions that were previously 
observed have a net cytotoxic effect. Together with the in vitro result on C8J, this result 
	  	   vi	  
also suggests that C8J enhances the survivability of cells by restoring TDP-43 back to the 
nucleus. MATR3 biochemistry seems to connect to neurodegenerative diseases in several 
ways. Identifying the pathological connections between MATR3 and TDP-43 physiology 
will provide us with a greater understanding of ALS pathology. 
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INTRODUCTION 
 
 Amyotrophic lateral sclerosis is a human neurodegenerative disease that affects 
the motor neurons in the brain, spinal cord, and peripheral nervous system1. Clinical 
features are characterized by weakness of arms, legs, and face and difficulties with 
speech, swallowing and respiratory functions2. Current clinical observations suggest that 
it affects women and men, regardless of ethnicity, and risk increases substantially with 
age2. The clinical progression of ALS is one of the fastest among neurodegenerative 
diseases and the patients typically die from respiratory failure within 3 to 5 years after 
onset1-2. Currently, there is no cure for ALS. The only FDA approved treatment is 
Riluzole, which prolongs survival by three months1. The cause of the ALS is currently 
unknown. Approximately 10% of ALS is familial, and the remaining 90% of cases 
appear to be idiopathic1. Missense mutations in superoxide dismutase 1 (SOD1) have 
been identified more than 20 years ago in ALS patients, and population studies have 
suggested that mutation in SOD1 accounts for ~20% of the familial cases and ~2% of all 
cases3-4. This discovery has led to the creation of SOD1 transgenic mice. The usefulness 
of this model to screen for therapeutic agents in human trials has been repeatedly called 
into question because treatment that suppressed symptoms in SOD1 mutant mice have 
consistently failed in human trials5. In addition, the pathology of SOD ALS is distinctive 
in that it lacks the TDP-43 positive cytoplasmic inclusions or FUS pathology present in 
other ALS pathologies6. With this discovery, many researchers have begun to explore 
new mechanisms of ALS pathogenesis.  
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More recently, TAR DNA-binding protein (TARDBP) has been identified as a major 
component of the ubiquitin-positive neuronal inclusions that are the hallmarks of ALS 
and fronto-temporal dementia (FTD) 7. TDP-43 normally resides inside the nucleus, but 
pathological inclusions containing TDP-43 tend to aggregate in the cytosol, which 
suggests that subcellular protein disposition is a crucial step in ALS pathogenesis7. 
Although TDP-43 has been subjected to great investigation, little is known about whether 
the pathology is due to a gain of toxic function or loss of important biological functions. 
Moreover, very little is known about the pathways of TDP-43 pathogenesis or how other 
key players interact with TDP-43 that contributes to the pathogenesis of the disease.  
The discovery of TDP-43 in ALS pathology has highlighted the importance for RNA 
processing in neurodegenerative diseases. Subsequently, FUS and other RNA-binding 
proteins have been discovered8,9. We propose that the pathological inclusions of many 
neurodegenerative diseases proceed through the stress granule pathway, and mutations in 
key stress granule proteins or prolonged stress lead to increased stress granule formation 
and pathological inclusion in neurodegenerative diseases10. Recently, Johnson et al. 
found that mutations in MATR3 genes are associated with familial ALS11. Thus, we shift 
attention to MATR3-an important RNA- and DNA-binding protein-that interacts with 
TDP-43, in effort to understand how its mutations might play a role in ALS pathology.  
Although the biochemistry of MATR3 has been studied extensively, very little attention 
has been given to its relevance in neurology. It is known to bind and stabilizes mRNA12, 
retain hyper-edited RNA13, regulate formation of RNAi14, chaperone stem cell 
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differentiation15, and more. Thus, we set out to explore the interactions of MATR3 with 
TDP-43, in effort to clarify its role in ALS pathogenesis. 
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METHODS  
Cell Lines 
HT-22 (Murine hippocampal cell line) cells were grown in Dulbecco’s Modified Eagle 
Medium (DMEM) plus 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% 
nonessential amino acid (Fisher) at 37 C and 5% CO2 atmosphere. 
 
Plasmids 
 
 The TDP-43 A315T and wild type cDNAs were inserted into a pEGFP-C1 vector 
at BamH1/XbaI sites. The MATR3 S85C and wild type cDNAs were inserted into a 
pmCherry vector at BamHI/Xho1 sites modified to express monomeric mCherry 
fluorophore. Cloning was performed by Shamol Saha (Boston University School of 
Medicine). 
 
Cell Culture and Transfection for Fluorescence Microscopy  
12mm coverslips (Fisher Scientific) were washed with concentrated nitric acid overnight 
to remove any organic contaminants. The coverslips were then washed with distilled 
water until pH returns to 7. When coverslips were completely dry, the cleaned coverslips 
were coated with 1% poly-L-lysine solution overnight in 12 wells plates (Falcon). The 
poly-L-lysine coated slips were washed with deionized water three times under sterile 
conditions before culture.  
HT-22 cells were plated on to poly-L-lysine coated slips (60,000 cells/coverslip) and 
cultured overnight in DMEM plus 10% fetal bovine serum, 1% penicillin/streptomycin, 
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and 1% nonessential amino acid. After 20 hours, serum free media was replaced in 
preparation for transfection. Lipofectamine 2000 (Invitogen) solution was prepared 
separately with Opti-MEM Reduced Serum Medium, mixed well and incubated at room 
temperature for 15min. TDP-43 and MATR DNA samples were prepared and mixed with 
lipofectamine solution at a ratio of 1µg/2µL and incubated at room temperature for 20 
min. For each sample, 600ng of MATR3 and TDP-43 DNA was added for a total of 
1.2µg DNA per well. After 12 hours of transfection, culturing medium was replaced and 
experiments were initiated 24 hours after transfection. 
 
Stress Induction 
1mM of Sodium Arsenite was prepared in deionized water and filtered with Corning 
vacuum filters. The desire concentration of 7µM NaAsO2 solution was prepared by 
titrating the proper amount of 1mM NaAsO2 with culture medium. Cells were then 
treated with the 7µM NaAsO2 medium for 24 hours. All stress experiments were initiated 
24 hours after transfection. 
 
Immunocytochemistry 
HT-22 cells were grown on poly-L-lysine-coated slips and were treated 7µM NaAsO2 for 
24 hours. Following treatment, the cells were rinsed with PBS, fixed with 4% 
paraformaldehyde for 15 min, permeablized with 0.2% Triton-X100/PBS for 10 min, and 
blocked for 1 hour in PBS containing 10% donkey serum. The primary antibody used 
were: goat anti-eIF3α (1:200, Santa Cruz Biotechnology, Inc, sc-16377), rabbit anti-
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DDX6 (1:400, Berthyl Laboratory, Inc), and goat anti-TIA-1 (1:200, Santa Cruz 
Biotechnology, Inc, sc-1751). Secondary antibodies used were: Dylight 405 conjugated 
donkey anti-rabbit IgG and Dylight 405 conjugated donkey anti-mouse IgG (1:400, 
Jackson ImmunoResearch). Samples were incubated with primary antibodies in 5% 
donkey serum/PBS, overnight at 4 C. After, cells were washed three times with PBS, and 
were subsequently incubated with secondary antibodies diluted in PBS for 1 hour at room 
temperature, covered from light. Cells were then washed three times with PBS, one time 
with 0.2%Triton-X100/PBS, and then one last time with PBS. The coverslips were then 
mounted on glass microscope slides (Fisher Scientific) using 8 µL of Prolong-Gold Anti-
fade reagent (Invitrogen). Slides were then left to dry overnight in fume hood and sealed 
using clear nail polish.  
 
C8J experiments 
C8J dissolved in dimethyl sulfoxide was obtained as 30mM solution from Dr. Benjamin 
Wolozin. In previous high content screening, the EC50 was determined to be 200nM. The 
desired concentration of 5µM was prepared from titrating with the proper volume of 
30mM C8J. Cells were then treated with 5µM C8J for 24 hours against stress and 
MATR3 pathology to determine its possible therapeutic effect. 
 
Microscopy 
Fluorescence microscopy was performed using a Carl Zeiss Axio Observer.Z1 carrying 
lasers at 405, 488, 543 and 633nm. All images were captured using a 40 or 63X len. Zen 
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Pro was used for digital image analysis. Imaris Bitplane was used for analysis of 
subcellular inclusions. Images were prepared and combined into figures for the 
manuscript using Adobe Illustrator and Adobe Photoshop software.  
 
Fluorescence Activated Cell Sorting (FACS) 
All FACS experiments were performed using FacsCalibur (BD Biosciences) carrying 
488nm Argon laser with three fluorescence channels at 515-545nm, 564-606nm and  
>650nm. 
Cells were grown on 12-well plate (Falcon), harvested using 0.25% trypsin-EDTA 
solution (Sigma), and subsequently washed with PBS and Binding Buffer (eBioscience, 
cat. 00-0055). Each cell sample was resuspended in 75µL of Binding Buffer, and 2.5µL 
of Annexin V PE (eBioscience, cat. 12-8102) was added to the cell suspension and mixed 
well. The cells were incubated at room temperature for 20 min, and subsequently washed, 
transferred to 5mL polystyrene round-bottom tubes (BD Falcon) and resuspended in 
250µL of Binding Buffer. Then, 2.5µL of 7AAD Viability Staining solution 
(eBioscience, cat. 00-6993) was added to each sample, mixed well, and readied for FACS 
analysis. For proper compensation, Negative control was unstained cells, and positive 
control was prepared by 90ºC heat shock with Annexin V PE and 7AAD Viability 
Staining solution. 
 
Statistical Analysis 
All statistical analysis was done using one-way ANOVA followed by t-test. Statistical 
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calculations were performed using R-statistics program. Error bars in figures are shown 
as standard error of the mean. 
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RESULTS 
 
 
Figure 1. MATR3 
colocalizes with TDP-43. 
HT22 cells were 
transfected with plasmids 
encoding eGFP-WT TDP-
43, eGFP-TDP-43 A315T 
and/or mCherry-WT 
MATR3, mCherry-
MATR3 S85C. 
MATR3 S85C. MATR3 
colocalizes with TDP-43. 
Normally MATR3 is 
localized to the nucleus. 
Under basal conditions, 
HT22 cells transfected 
with WT TDP-43 and WT 
MATR3 shows mainly 
localization TDP-
43/MATR3 in the nucleus 
with occasional 
cytoplasmic inclusions. 
S85C mutation of MATR3 
greatly increases the 
formation of both TDP-43 
and MATR3 cytoplasmic 
inclusions. The 
translocation effect is 
observed most 
dramatically in mutant 
TDP-43 and MATR3 
condition, where TDP-43 
and MATR3 is almost 
completely absent from the 
nucleus. It is interesting to 
note that HT22 cells that 
are only transfected with 
MATR3 exhibit a 
“stretched out” 
morphology.  
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Matrin 3 colocalizes with TDP-43 
 
The mislocalization of TDP-43 is a hallmark of ALS pathology7. TDP-43 normally 
resides in the nucleus, but the pathogenesis of ALS involves abnormal localization of 
TDP-43 in the cytoplasm, forming insoluble aggregates7. Many investigators, including 
our lab, have reported that TDP-43 regulates RNA processing through the stress granule 
pathway10,16.  The discovery of TDP-43 proteopathy in ALS has prompted the discovery 
of other key factors that regulate RNA metabolism. Johnson et al. reported that a series of 
mutations in MATR3 cause familial ALS11. A Ser85Cys missense mutation was 
Figure 2.  MATR3 modifies TDP-43 subcellular 
location and aggregation propensity. A.) 
Quantification of number of TDP-43-positive 
cytoplasmic inclusions per cell using Imaris Bitplane. 
There is a 6 fold increase in number of cytoplasmic 
inclusion from WT TDP-43 + WT MATR3 to WT 
TDP-43 + MATR3 S85C. ~25 fold increase in 
cytoplasmic inclusions/cell from WT to mutant TDP-43 
and MATR3. *, p < 0.05; **p < 0.001; *** p < 0.0001. 
B.) Quantification of total number of TDP-43 positive 
inclusions. Mutations in MATR3 and/or TDP-43 greatly 
increases total number of TDP-43 inclusions. *, p < 
0.0001. C.) Colocalization analysis shows that TDP-43 
physically interacts with MATR3 in vitro. 
A. 
B.	  
C.	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previously reported to cause autosomal dominant, distal, asymmetric myopathy with 
vocal cord paralysis17,18. Further clinical findings reclassify these symptoms as slow 
progressive forms of ALS11. To test whether Matrin 3 interacts with crucial disease 
proteins of ALS, murine hippocampal cell lines HT22 were transfected with WT TDP-43 
or TDP-43 A315T constructs N-terminally tagged with EGFP, and WT MATR3 or 
MATR3 S85C constructs N-terminally tagged with mCherry (Figure 1). Our result shows 
that cells that were transfected with WT TDP-43 had few cytoplasmic and total TDP-43 
inclusions, which concurs with previous reports that full length TDP-43 predominantly 
resides in the nucleus under basal conditions16. WT TDP-43 has ~2.5 inclusions/cell and 
~11 total. Cells that were transfected with TDP-43 A315T (a known mutation that causes 
ALS) exhibit a significant increase in total number of cytoplasmic inclusions (Figure 2), 
which conforms with the report by Liu-Yesucevitz et al. that mutations in TDP-43 causes 
aggregation of TDP-43 and stress granule associated proteins16. TDP-43 A315T has 
~1/cell and ~33 inclusions total. The WT MATR3 and WT TDP-43 are predominantly 
Figure 3. Mutation in MATR3 causes translocation of MATR3 and increase formation of 
cytoplasmic MATR3 positive inclusions. HT22 cells were transfected with mCherry-WT MATR3 or 
mCherry-MATR3 S85C. Quantification of MATR3 inclusions indicates that S85C mutation in 
MATR3 increases both the cytoplasmic and total number of MATR3 inclusions. *, p < 0.001. 
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nuclear under basal conditions in vitro (Figure 2). No granule formation is observed for 
WT MATR3, however, an increase in cytoplasmic and total granule formation is 
observed with the S85C mutation, suggesting that mutation in MATR3 correlates with 
the pathological phenotype. We show that an average cell with WT MATR3 has 0 matrin 
inclusions per cell, while a cell with MATR3 S85C has 4 inclusions on average (Figure 
3). Cells expressing both TDP-43 and MATR3 show that the majority of TDP-43 
colocalizes with MATR3, which demonstrates that MATR3 physically interacts with 
TDP-43. In all conditions, more than 90% of TDP-43 colocalized with MATR3(Figure 
2C). In addition, our colocalization data show that MATR3 S85C has a greater 
interaction with TDP43 than WT MATR3. The S85C mutation correlates with a 1.2 fold 
increase in interaction compared with WT MATR3, which concurs with previous reports 
from Johnson et al. that the S85C mutation has the strongest effect on TDP-43 structure 
Figure 4. Disease-linked MATR3 mutation enhances the size of stress granule formation. 
Size of cytoplasmic inclusion analysis shows that S85C mutation in MATR3 induce larger TDP-43 
and/or MATR3 positive inclusions. A.) No MATR3 positive inclusion larger than 0.5µm is observed 
for WT MATR3. ~1.2µm inclusions are observed for MATR3 S85C. *, p < 0.001. B.) No TDP-43 
positive inclusion larger than 0.5µm is observed for WT MATR3 and TDP-43. Size 0.95, 1, 1.35µm 
TDP-43 positive inclusions are observed for WT TDP-43 + MATR3 S85C, TDP-43 A315T + WT 
MATR3 S85C, and TDP-43 A315T + MATR3 S85C respectively. *, p < 0.001; **, p < 0.0001. 
A
. 
B. 
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and affinity11 (Figure 1, 2C). Most importantly, this result shows that MATR3 modifies 
TDP-43 subcellular location. Under the WT TDP-43 and WT MATR3 condition, there 
are very few total and cytoplasmic inclusions (Figure 2A). Introduction of the S85C 
mutation greatly increased the number of cytoplasmic and total inclusions, which 
indicates that MATR3 substantially modifies TDP-43 pathology. When the condition of 
WT TDP43 and WT MATR3 was compared with WT TDP43 and S85C MATR3, we 
observed about a 6-fold increase in total inclusions (Figure 2B). The greatest number of 
inclusions was observed in the double mutant condition, with TDP-43 A315T and 
MATR3 S85C. In that condition both TDP-43 and MATR3 are almost completely absent 
in the nucleus and instead are observed as cytoplasmic inclusions (Figure 2B). This 
represents about a 25-fold increase from the pure wild type condition (Figure 2B). It is 
also interesting to note that when WT TDP-43 is expressed together with WT MATR3, 
less inclusions were observed compared with TDP-43 alone, which suggests a potential 
protective function of WT MATR3 from aberrant TDP-43 localization (Figure 2B). WT 
TDP-43 alone has about cytoplasmic inclusions per cell, while WT TDP-43 co-expressed 
with WT MATR3 has ~0.5 inclusion/cell (Figure 2B). Large, insoluble, cytoplasmic 
inclusions in neuronal cells are defining characteristics of most neurodegenerative 
disorders7. This prompted us to investigate how MATR3 might modify the size of TDP-
43 positive inclusions. We developed an algorithm to detect granule sizes greater than 
0.5µm using Imaris Bitplane, and ran this algorithm on our images to assess the average 
size of granules in each condition. We found that the S85C mutation causes a significant 
increase in the size of both TDP-43 and MATR3 granules, while the WT TDP-43 & WT 
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MATR3 condition shows no large inclusions, which may suggest that WT MATR3 has a 
protective effect while mutations such as S85C have a role in pathological phenotypes 
(Figure 4). Cells with WT MATR3 had no matrin 3 inclusions greater than 0.5µm, while 
cells with MATR3 S85C had inclusions with an average size of 1.2µm. Double wild type 
cells had no inclusions greater than 0.5µm, while cells with WT TDP43 alone showed 
inclusions with average size of 0.9µm. Observations of either MATR3 S85C or TDP43 
A315T showed larger inclusions around 1µm in size, while cells with the double 
mutation condition had very large inclusions around 1.3µm (Figure 4). 
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Figure 5. The effect 
of MATR3 on TDP-
43 is greatly 
enhanced by stress. 
HT22 was expressed 
with wild type and 
mutation of TDP-43 
and MATR3. Cells 
were exposed to 
simulated stress (7µM 
NaAsO2, 24 hrs) WT 
TDP-43 shows little 
inclusion formation, 
while MATR3 
mutation greatly 
increase the number 
and the size of TDp43 
inclusions. 
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The effect of MATR3 on pathology is greatly enhanced by stress 
Many investigators have reported than protein aggregation increases under stressful 
conditions. To investigate how MATR3 aggregations might be different in a stressful 
environment, HT22 cells were exposed to 7µM sodium arsenite for 24 hours. Arsenite 
causes stress through multiple pathways and is commonly used as stress inducer for 
neurological studies19. Arsenite can directly cause oxidative stress by oxidizing oxygen 
and producing superoxides in a process analogous to the well-known Fenton reaction19. 
Arsenite also oxidizes glutathione, which is further conducive to oxidative stress19. 
Metabolic responses to arsenite include synthesis of heat shock proteins, stimulation of 
NFkB and increased synsthesis of glucose regulated proteins and transporters19. Many of 
the stress responses to arsenite are known to inhibit protein translation and induce stress 
granule formation, which makes arsenite an excellent stress inducer for stress granule-
related studies19. Many studies previously have used various concentrations and exposure 
times of arsenite. 7µM sodium arsenite for 24 hours was chosen to more closely mimic 
the slow and prolonged stress involved in neurodegeneration. Upon exposure to arsenite 
WT TDP-43 remained largely nuclear with very little presence of inclusions and 
translocation to the cytoplasm. The expression of MATR3 S85C causes the formation of 
very large 3-5µm inclusions, while WT TDP-43 with WT MATR3 forms more smaller 1-
2µm inclusions (Figure 5).  
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 MATR3 inclusions are TDP-43 positive but are not stress granules. 
In our previous vitro experiment, we were able to show that MATR3 colocalizes with 
TDP43, and mutation in MATR3 causes mislocation and formation of large cytoplasmic 
TDP-43 positive inclusions that are characteristic of ALS pathology. To gain further 
insight into MATR3 pathway and functions, immunocytochemistry was performed to 
characterize MATR3 inclusions and identify its components. HT22 cells were transfected 
Figure 6. MATR3 
inclusions are 
adjacent to SGs, 
but are not SGs. 
HT22 cells 
transfected with 
plasmids encoding 
eGFP- TDP-43 
A315T and 
mCherry-MATR3 
S85C, were exposed 
to stress (7µM 
NaAsO2, 24 hrs). 
Subsequently, cells 
were immunostained 
for eIF3α. MATR3 
colocalizes with 
TDP-43 but not 
eIF3α (indicated by 
white arrows). 
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with eGFP-TDP-43 A315T + mCherry-MATR3 S85C and exposed to arsenite (7µM, 
24hr). The cells were fixed and then immuno-labeled with antibodies to eIF3α, a stress 
granule marker. A notable feature of stress granules compared to other RNA granules is 
that they contain translation initiating factors and 40S ribosomal subunits. Therefore eIF3 
is an ideal marker for stress granules. Similar to our previous result, most of the TDP-43 
and MATR3 translocated to the cytoplasm and formed large inclusions, and a majority of 
the TDP-43 inclusions were colocalized with MATR3 (Figure 6. Yellow indicates 
colocalization of TDP-43 and MATR3). A proportion of TDP-43 inclusions were found 
to be eIF3α positive, which agrees with many previous findings that TDP-43 is a part of 
the stress granule10,16 (purple indicates eIF3α positive TDP-43 granules). However, 
interestingly, MATR3 inclusions were not eIF3α positive, suggesting that MATR3 is not 
a part of the stress granule complex. Our result indicates that TDP-43 is a component of 
both MATR3 granules and stress granules, and that MATR3 inclusions are directly 
adjacent to stress granules or eIF3α inclusions, suggesting that, while not being a part of 
stress granule complex, MATR3 granules are involved in RNA processing via the stress 
granule pathway by relaying crucial components such as TDP-43.  
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MATR3 inclusions are not P-bodies 
Several key features of MATR3 granules include forming inclusions with TDP-43, not 
being stress granules, and residing physically next to stress granules. All these features 
led us to investigate the possibility that MATR3 granules might be processing bodies (p-
bodies). P-bodies are discrete cytoplasmic domains and known to be involved in mRNA 
degradation, translational repression, and RNA-mediated gene silencing20. Under stress 
conditions, they are found closely associated to stress granules and have been observed to 
exchange components with stress granules20. To test whether MATR3 granules are p-
bodies, immunocytochemistry was performed to stain for DDX6 positive inclusions. 
DDX6 is a major component of p-bodies and its functions include translational 
suppression and mRNA degradation, and microRNA-induced gene silencing21. HT22 
cells were transfected with eGFP-TDP-43 + mCherry-MATR3, and exposed to arsenite 
Figure 7. MATR3 inclusions are not p-bodies. HT22 cells transfected with plasmids encoding eGFP- 
WT/mut TDP-43 and mCherry-WT/mut MATR3, were exposed to stress (7µM NaAsO2, 24 hrs). 
Subsequently, cells were immunostained for DDX6. MATR3 colocalizes with TDP-43 but not DDX6. 
 
	  20 
(7µM, 24hr). The cells were fixed and then immuno-labeled with antibodies to DDX6. 
DDX6 was stained blue, and our result shows that cherry MATR3 granules were not 
stained with DDX6 (Figure 7), which suggests that the MATR3 granules did not contain 
any DDX6 and therefore are not p-bodies.  
 
C8J alleviates TDP-43 and MATR3 pathological inclusions 
 
Figure 8. Compound 8J reverses MATR3 induced cytoplasmic inclusion with no significant 
cytotoxicity in vitro. HT22 cells transfected with plasmids encoding eGFP- TDP-43 A315T and 
mCherry-MATR3 S85C, were exposed to stress (7µM NaAsO2, 24 hrs) and C8J (5µM 24hrs). No 
difference in cell viability and morphology is observed under basal conditions. Under stress condition, 
C8J inhibits and reverses TDP-43 and MATR3 cytoplasmic inclusions comparing to the untreated. 
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As we mentioned previously, there is currently no cure for ALS, and the only FDA 
approved treatment for ALS is Riluzole, which prolong patients’ survival for an average 
of three months1. Riluzole blocks TTX sensitive sodium channels, which associate with 
neuronal damage by excitotoxicity22. This method alleviates some symptoms of ALS 
with detrimental side effects and does not target the central cause. With greater 
understanding of ALS pathology and new technologies such as high throughput 
screening, we are more hopeful to find treatments that target the core pathology of ALS. 
In a recent high-content screen for compounds that inhibit stress-induced TDP43 
aggregation, C8J was found to be effective at inhibiting TDP43 aggregation. Our results 
have shown MATR3 as an important modifier of TDP-43 pathology, as the S85C 
mutation of MATR3 greatly increased TDP-43 aggregation. To determine if C8J is 
effective at inhibiting MATR3 induced TDP-43 aggregation, HT22 cells were plated and 
transfected with eGFP-TDP-43 A315T + mCherry-MATR3 S85C, and treated with 5µM 
C8J. The cells were divided into two groups: a basal condition group and a stress 
condition group that was treated with 7µM arsenite for 24 hours (Figure 8). Under no 
stress, we found that there was no difference between cells treated with C8J and cells that 
were not. This suggests that C8J has no innate toxicity. Under stress conditions, the 
untreated cells show striking TDP-43 pathology, in that most of all the TDP-43 was 
absent in the nucleus and translocated to the cytoplasm where it formed inclusions. Stress 
condition cells that were treated with C8J, however, showed significantly less 
cytoplasmic TDP-43 inclusions. Most interestingly, the mostly nuclear TDP-43 indicates 
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that C8J not only inhibits TDP-43 aggregation, but also reverts TDP-43 back to its 
nuclear state.  
 
Fluorescence activated cell sorting (FACS) experiment shows important MATR3 
physiology 
A. 
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One of many important unanswered questions in RNA processing is the potential 
consequences of stress granule (SG) persistence10. On one hand, SGs protects neurons 
from toxic proteins and oligomers. On the other hand, as we hypothesize, the persistence 
and accumulation of SGs in neurons might lead to a loss of normal function and produce 
toxic pathological SGs10. Thus, it is important to perform cytotoxicity experiments to 
confirm whether disease-linked mutations in MATR3 that increase SG formation are 
responsible for low cell survivability. In preparation for FACS, HT22 cells were 
transfected with 8 different conditions shown above (Figure 9) plus 4 control conditions 
(unstained, unstained eGFP + βgal, heat shocked cell + Annexin V PE, heat shocked cells 
+7AAD). The controls were necessary for FacsCalibur instrument settings and fine-
tuning of detector amps and compensation. After 24 hours of transfection, cells were 
washed and stained with both annexin V PE (apoptosis marker) and 7AAD (cell viability 
marker). Annexin V is a phosphatidylserine marker, and when cells undergo apoptosis, 
Figure 9. TDP-43 rescues 
cytotoxicity by high level 
of MATR3 expression in 
HT22 cells. HT22 cells 
transfected with only 
MATR3 have very low 
viability, while co-
expression with TDP-43 
greatly enhances cell 
viability.A.) FACS analysis 
on WT MATR3 shows 
high population in Q3 and 
Q4, indicating that majority 
of the cells are in early and 
late apoptosis. B.) 
Quantification of FACS 
data. 
B. 
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phosphatidylserine is expressed on the surface and therefore marked by annexin V23. In 
order to stain cells that die and lose integrity, the DNA intercalating agent 7AAD was 
used. The combination of annexin V PE and 7AAD assay can distinguish viable cells 
from apoptotic and necrotic cells. Viable cells would not be stained by either annexin or 
7AAD. Cells undergoing early apoptosis would be stained by annexin V only. Cells 
undergoing late apoptosis would be stained by both annexin V and 7AAD, and necrotic 
cells would be stained only by 7AAD. Next, stained cells were analyzed by FacsCalibur. 
Detector amps and other parameters were set based on controls, and FACS data were 
obtained for each condition based on a sample of 20,000 cells/condition. Our results 
indicated that over-expression of MATR3 is toxic for the HT22 cells. Less than 10% of 
cells were viable for the WT MATR3 condition (Figure 9). TDP-43, however, seems to 
reduce cytotoxicity, with the expression of TDP-43 bringing viability back to 30%+ 
compared with MATR3 alone. Previous reports have suggested that MATR3 is an 
important factor for neuronal cell death in response to NMDA-type glutamate receptor 
activation24. However, the explanation for this is not straightforward since reports have 
also confirmed that HT22 cells lack glutamate receptors25. This interesting MATR3 
physiology shall be discussed further later on. Our result does not give us insight to the 
pathology of MATR3, because there is no observed pattern in the variation from WT to 
mutation. Further considerations needs to be made to improve the assay to distinguish 
pathology from normal phenotype. 
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Figure 10. Compound 8J 
ameliorates MATR3 and TDP-
43 induced cytotoxicity.  Our 
FACS experiment indicates that 
there is a significant increase in 
viability (Q4) in WT TDP-43 + 
WT MATR3 when treated with 
C8J. WT TDP-43 + WT 
MATR3 viable cell population 
have increased from 39% to 
47% (Q4) when cells were 
exposed to 5µM C8J 24 hrs 
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Previously, we have shown that C8J reverted the MATR3 induced TDP-43 inclusions 
back to the nucleus. To assess this effect on cytotoxicity, HT22 cells were plated and 
transfected with either WT TDP-43 WT MATR3 (double wild type condition) or TDP-43 
A315T MATR3 S85C (double mutant condition), and subsequently treated with 5µM 
C8J (24 hrs). Our result indicates that there is a significant increase in viability in WT 
TDP-43 + WT MATR3 when treated with C8J (WT TDP-43 + WT MATR3 viable cell 
population have increased from 39% to 47% when cells were exposed to 5µM C8J 24 
hrs), which suggests that the TDP-43 and MATR3 cytoplasmic inclusions that were 
previously observed have a net cytotoxic effect. Together with our previous in vitro result 
on C8J, this result also suggests that C8J enhances the survivability of cells by restoring 
TDP-43 back to the nucleus. For the double mutant TDP-43 A315T + MATR S85C, C8J 
was less effective at reducing cytotoxicity (TDP-43 A315T + WT MATR3 S85C viable 
cell population only increased from 37% to 38% when cells were exposed to 5µM C8J 24 
hrs). Although the increase in viability is small, the result is still statistically significant 
(p<0.01) as over 20,000 cells were sampled from each FACS analysis. 	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DISCUSSION 
 
Many reports have suggested that mutations in RNA-binding proteins either directly or 
indirectly contribute to ALS pathogenesis16,26. Mutations in TDP-43 and FUS, proteins 
involved in pre-RNA splicing, transport and translation, led to the theory that aberrant 
RNA processing is behind the pathogenesis of ALS. There is increasing evidence 
indicating that aberrant protein aggregation in neurodegenerative disease proceeds 
through the stress granule pathway10. Subsequent studies have verified that RNA binding 
proteins that are known to cause familial ALS, such as TDP43, are found sequestered into 
stress granules16. Under oxidative stress or starvation, TDP-43 is translocated to the 
cytoplasm and accumulates into stress granules via prion-like mechanisms27. And when 
stress is resolved, stress granules disintegrate with the help of disaggregases and 
chaperones, which allows TDP-43 to relocate back into the nucleus where it proceeds 
with its normal function27. It is still unclear how the stress granule pathway is related to 
the mechanism by which mutant TDP-43 causes ALS. Nevertheless, discovery of 
modifiers of TDP-43 such as ataxin 2 (ATXN2), has given great insights into TDP-43 
proteopathy28. In our experiments, we investigated MATR3, another potentially crucial 
modifier of TDP-43, and demonstrated that MATR3 colocalizes with TDP-43. Our 
experiments showed that a mutation in MATR3 associated with familial ALS enhances 
the formation of cytoplasmic TDP-43 inclusions in response to stress. S85C mutation in 
MATR3 in vitro induces, larger and more numerous TDP-43 and MATR3 positive 
inclusions compared to the wild type. The hallmark manifestation of ALS pathology is 
“larger, round and Lewy body-like inclusions7,” which is what we observed with the 
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mutant MATR3. 
The immunocytochemistry has revealed that MATR3 inclusions are directly 
adjacent to stress granule or eIF3α inclusions but are not part of stress granule 
complexes. Subsequent immunocytochemistry revealed that MATR3 is not a part of p-
bodies, as it is not stained by DDX6 (a major component of p-bodies involved in RNA 
degradation). The precise nature of MATR3 granules is currently a mystery. Our results 
suggest that MATR3 granules share TDP-43 with stress granules, and we hypothesize 
that while not a part of stress granule, MATR3 is closely associated with RNA 
metabolism via the stress granule pathway by relaying crucial components such as TDP-
43. Another crucial player in RNA metabolism is autophagy. One next step for future 
research into MATR3 is to see if MATR3 granules are autophagosomes. Further research 
might require MATR3 immunoprecipitation (IP) and mass spectrometry. However, a 
method of separating RNA granules is difficult to devise, and cell lysate IP produces 
irrelevant data with a very low signal to noise ratio. Nevertheless, identifying key 
components of MATR3 granules would give us insights on how MATR3 modifies TDP-
43 pathology.  
Many reports imply that localization of cytoplasmic aggregates as stress granules 
is a crucial step in ALS pathogenesis7,10,16,28. A compound that relocates TDP-43 and 
thereby mitigates prolonged stress granule mediated translational repression is proposed 
as a possible therapeutic for ALS10. Our results show that C8J is able to disaggregate and 
relocate TDP-43 and MATR3 positive inclusions in vitro. Although the mechanism of 
action of C8J is still unknown, the results obtained with FACS indicate a significant 
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increase in viability when HT22 cells over-expressed with WT TDP-43 + WT MATR3 
were exposed to C8J. C8J was not as effective on the double mutant cells (TDP-43 
A315T + MATR3 S85C). Clinical findings have shown that TDP-43 positive inclusion 
from over-expression of WT TDP-43 is a hallmark of sporadic ALS6,7, which suggests 
C8J as a potential therapeutic compound for sporadic ALS. 
 
 
Our FACS experiment shows that over-expression of MATR3 greatly increases 
cytotoxicity, and expression of TDP-43 increases HT22 cell viability by 5-6 fold. 
Interestingly, in our previous experiment, we found that MATR3-expressed HT22 cells 
showed a more stretched-out morphology compared with other conditions, which 
suggests that MATR3 could induce differentiation of HT22 cells. Furthermore, He et al. 
report that differentiated HT22 gains glutamate receptors, which renders differentiated 
HT22 more susceptible to excitotoxicity29. We hypothesize that MATR3 induces HT22 
cells to differentiate and gain glutamate receptors, and, consequently, increase 
cytotoxicity by rendering HT22 cells more susceptible to excitotoxicity. Further 
Figure 11. HT22 
cells transfected 
with MATR3 
show a 
“Stretched out” 
cell morphology, 
which suggests 
that MATR3 
could induce 
differentiation of 
HT22 cells. 
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experiments are needed to test this hypothesis. To our disappointment, we did not see a 
significant difference in viability between mutated MATR3 and wild type. Since most 
neurodegenerative diseases begin innocuously with mild symptoms and progress 
gradually, we suspect that a better model needs to be devised for toxicity studies. Perhaps 
long-term expression of MATR3 is required to see a more dramatic effect on neuron 
viability. For our future cytotoxicity studies, we can design lentivirus that carries MATR3 
and TDP-43 genes and create stable long-term expression lines. This might give us a 
more accurate model of neurodegeneration and more fully capture the effect of MATR3 
mutation on cell viability and pathology. 
MATR3 and its biochemistry have studied extensively. MATR3 has gone mostly 
unnoticed in neurological research, until the discovery by Johnson et al. that MATR3 
related mutations are found in patients with familial ALS11. It is known to be involved in 
RNA processing12. Interestingly, it has been found as a component in paraspeckles that 
play an important role in retention of hyper-edited RNA13,30, which regulates Ca2+ influx 
and acts as a regulator for many important cellular responses, such as post-translational 
protein modifications31 as well as cell death in response to glutamate-activated 
receptors24. Furthermore, MATR3 is component of argonaute-containing complex that 
silences mRNA and regulate miRNA metabolism14. Many in vivo studies show that there 
is an increase in ALS mice of muscle and motor neuron specific miRNA compared with 
healthy mice32. MATR3 biochemistry seems to connect to neurodegenerative diseases in 
several ways. Identifying the pathological connections between MATR3 and TDP-43 
physiology will provide us with greater understanding of ALS pathology.	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